• Asuragen launches assay to help diagnose Steinert's Disease

    6 days ago - By News Medical

    Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced the CE marking and launch of the AmplideX DM1 Dx Kit, which simplifies the analysis of repeat expansions within the DMPK gene and is intended to aid in the diagnosis of Myotonic Dystrophy Type I , also known as Steinert's Disease.
    Read more ...